Davis's Drug Guide
Tri–Linyah
Phase I
norgestimate 0.18 mg + ethinyl estradiol 35 mcg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Tri–Linyah." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110007/all/Tri–Linyah.
Vallerand AHA, Sanoski CAC. Tri–Linyah. Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110007/all/Tri–Linyah. Accessed July 14, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Tri–Linyah. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110007/all/Tri–Linyah
Vallerand AHA, Sanoski CAC. Tri–Linyah [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 July 14]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110007/all/Tri–Linyah.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tri–Linyah
ID - 110007
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110007/all/Tri–Linyah
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -
